Michael Kranda - Director, Ptc Therapeutics, Inc

As of March 18, 2015


Michael Kranda Net Worth

  • Net worth is estimated to be at least $314.49K
  • Owns at least 2,242 units of Ptc Therapeutics, Inc stock
  • Sold an estimated value of $218.83K in the last year at Ptc Therapeutics, Inc

Michael Kranda Trading

  • Largest sale of shares was 2,500 units , worth over $182.04K on March 18, 2015
  • In total has made about 4 transactions over a year
  • Usually trades in March and January, with the busiest year in 2015 and 2014
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Michael Kranda Mailing Address

  • Mailing address is C/o Vulcan Ventures Incorporated 505 Fifth Avenue, Suite 900 Seattle WA 98104 WA

Ptc Therapeutics, Inc Insider Trading

  • The most recent transaction was 897 units sold on April 21, 2022 by Matthew Klein worth over $38.14K
  • In the last 9 years, insiders at Ptc Therapeutics, Inc sold an estimated value of $159.5M and bought an estimated value of $101.25M
  • The most active traders are Walter Stuart Peltz, CHIEF EXECUTIVE OFFICER,  Gregory Neil Almstead, Chief Technical Ops Officer,  and Elliott Mark Boulding, EXEC. VP AND CLO
  • Insider trading is most common in January, with the busiest year in 2020

PTC THERAPEUTICS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1